NOTICE OF 2017 ANNUAL MEETING OF STOCKHOLDERS
TIME: 8:30 AM ET
DATE: Friday, June 9, 2017
PLACE: 10 Post Office Square, Suite 502 South, Boston, MA 02109
PURPOSES:
1. To elect two Class I directors to serve three-year terms expiring in 2020;
2. To approve an amendment to our Restated Certificate of Incorporation, as amended, to decrease the number of shares of
common stock authorized for issuance from 200,000,000 to 30,000,000;
3. To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending
December 31, 2017;
4. To approve, on an advisory basis, the compensation of our named executive officers as disclosed in this proxy statement;
5. To approve, on an advisory basis, the frequency of holding an advisory vote on compensation of our named executive officers;
and
6. To transact such other business as may be properly presented at the annual meeting or any adjournment or postponement
thereof.
WHO MAY VOTE:
You may vote if you were the record owner of Albireo Pharma, Inc. common stock at the close of business on April 18, 2017. A
list of stockholders of record will be available at the annual meeting and, during the 10 days prior to the annual meeting, at our
principal executive offices located at 10 Post Office Square, Suite 502 South, Boston, MA 02109
Zurück
